Epstein–Barr Virus Infection as an Epigenetic Driver of Tumorigenesis

作者: Atsushi Kaneda , Keisuke Matsusaka , Hiroyuki Aburatani , Masashi Fukayama

DOI: 10.1158/0008-5472.CAN-11-3919

关键词:

摘要: Epstein-Barr virus (EBV) establishes latent infection and is associated with tumors, such as Burkitt lymphoma, nasopharyngeal carcinoma, gastric cancers. We recently reported that EBV(+) cancer shows an EBV(+)/extensively high-methylation epigenotype, in vitro EBV induces extensive DNA methylation gene repression within 18 weeks. On the basis of absence both accumulation surrounding mucosa cancer, it suggested EBV-infected cell acquires to silence multiple tumor suppressor genes a short time period transforms into cells, not forming precancerous field or accumulation. The mechanism induced by has been fully clarified. Differences genome are dependent on different latency status other epigenomic alterations, 3-dimensional conformation histone modification, may affect host methylation. Expressions viral proteins small RNAs also depending status, some might trigger inducing methyltransferase overexpression. In this review, we discuss these roles driving tumorigenesis their possible association aberrant

参考文章(30)
Lawrence S. Young, Alan B. Rickinson, Epstein–Barr virus: 40 years on Nature Reviews Cancer. ,vol. 4, pp. 757- 768 ,(2004) , 10.1038/NRC1452
J J Hsieh, T Henkel, P Salmon, E Robey, M G Peterson, S D Hayward, Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Molecular and Cellular Biology. ,vol. 16, pp. 952- 959 ,(1996) , 10.1128/MCB.16.3.952
Shotaro Enomoto, Takao Maekita, Tetsuya Tsukamoto, Takeshi Nakajima, Kazuyuki Nakazawa, Masae Tatematsu, Masao Ichinose, Toshikazu Ushijima, Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae Cancer Science. ,vol. 98, pp. 1853- 1861 ,(2007) , 10.1111/J.1349-7006.2007.00625.X
C.-N. Tsai, C.-L. Tsai, K.-P. Tse, H.-Y. Chang, Y.-S. Chang, The Epstein–Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 10084- 10089 ,(2002) , 10.1073/PNAS.152059399
Natalie Motsch, Thorsten Pfuhl, Jan Mrazek, Stephanie Barth, Friedrich A. Grässer, Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biology. ,vol. 4, pp. 131- 137 ,(2007) , 10.4161/RNA.4.3.5206
Italo Tempera, Andreas Wiedmer, Jayaraju Dheekollu, Paul M. Lieberman, CTCF prevents the epigenetic drift of EBV latency promoter Qp. PLOS Pathogens. ,vol. 6, ,(2010) , 10.1371/JOURNAL.PPAT.1001048
Jennifer E. Cameron, Claire Fewell, Qinyan Yin, Jane McBride, Xia Wang, Zhen Lin, Erik K. Flemington, Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology. ,vol. 382, pp. 257- 266 ,(2008) , 10.1016/J.VIROL.2008.09.018
Seiji Maruo, Bo Zhao, Eric Johannsen, Elliott Kieff, James Zou, Kenzo Takada, Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 1919- 1924 ,(2011) , 10.1073/PNAS.1019599108
Masashi Fukayama, Tetsuo Ushiku, Epstein-Barr virus-associated gastric carcinoma. Pathology Research and Practice. ,vol. 207, pp. 529- 537 ,(2011) , 10.1016/J.PRP.2011.07.004